Antioxidants (Sep 2022)

Protective Effects of Natural Antioxidants on Inflammatory Bowel Disease: Thymol and Its Pharmacological Properties

  • Yao Liu,
  • Hui Yan,
  • Bing Yu,
  • Jun He,
  • Xiangbing Mao,
  • Jie Yu,
  • Ping Zheng,
  • Zhiqing Huang,
  • Yuheng Luo,
  • Junqiu Luo,
  • Aimin Wu,
  • Daiwen Chen

DOI
https://doi.org/10.3390/antiox11101947
Journal volume & issue
Vol. 11, no. 10
p. 1947

Abstract

Read online

Inflammatory bowel disease (IBD) is a gastrointestinal disease that involves chronic mucosal or submucosal lesions that affect tissue integrity. Although IBD is not life-threatening, it sometimes causes severe complications, such as colon cancer. The exact etiology of IBD remains unclear, but several risk factors, such as pathogen infection, stress, diet, age, and genetics, have been involved in the occurrence and aggravation of IBD. Immune system malfunction with the over-production of inflammatory cytokines and associated oxidative stress are the hallmarks of IBD. Dietary intervention and medical treatment suppressing abnormal inflammation and oxidative stress are recommended as potential therapies. Thymol, a natural monoterpene phenol that is mostly found in thyme, exhibits multiple biological functions as a potential adjuvant for IBD. The purpose of this review is to summarize current findings on the protective effect of thymol on intestinal health in the context of specific animal models of IBD, describe the role of thymol in the modulation of inflammation, oxidative stress, and gut microbiota against gastrointestinal disease, and discuss the potential mechanism for its pharmacological activity.

Keywords